The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Opinion article
Review
Original article
Clinical Characteristics and Disease Course in Patients Treated With Efalizumab Following Suspension of Marketing Authorization by the European Medicines Agency: A Multicenter Observational Study
L. Morell, J.M. Carrascosa, C. Ferrándiz, M. García-Bustinduy, E. Fonseca, G. Carretero, E. Daudén, S.E. Marrón, ... on behalf of the Spanish Psoriasis Group
Actas Dermosifiliogr. 2011;102:354-64
Full text access
Case report
Case for diagnosis
Case and research letters
Reproducibility of the Diagnosis of Onychomycosis by Dermatologists in a Clinical Setting
M. Cabanillas, I. García-Doval, B. Monteagudo, O. Suárez-Amor, F. Allegue, L. Pérez-Pérez, M. Ginarte, J. Labandeira, A. Zulaica
Actas Dermosifiliogr. 2011;102:387
Full text access
Physiological Desquamation of the Newborn: Epidemiology and Predisposing Factors
B. Monteagudo, J. Labandeira, E. León-Muiños, R. Romarís, M. Cabanillas, D. González-Vilas, A. Acevedo, R. Fernández-Prieto, J. Toribio
Actas Dermosifiliogr. 2011;102:391-4
Full text access

